CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 199 filers reported holding CLOVIS ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 0.94 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $390,000 | -77.1% | 28,400 | -68.0% | 0.01% | -80.0% |
| Q1 2016 | $1,705,000 | +508.9% | 88,826 | +2817.1% | 0.03% | +1400.0% |
| Q3 2015 | $280,000 | -54.3% | 3,045 | -56.3% | 0.00% | -60.0% |
| Q2 2015 | $613,000 | -24.6% | 6,973 | -36.3% | 0.01% | -37.5% |
| Q1 2015 | $813,000 | +74.8% | 10,955 | +32.0% | 0.01% | +166.7% |
| Q4 2014 | $465,000 | -45.5% | 8,300 | -55.9% | 0.00% | -40.0% |
| Q3 2014 | $853,000 | -41.1% | 18,800 | -46.3% | 0.01% | -28.6% |
| Q2 2014 | $1,449,000 | +546.9% | 35,000 | +982.6% | 0.01% | +600.0% |
| Q1 2014 | $224,000 | -32.7% | 3,233 | -40.9% | 0.00% | -50.0% |
| Q3 2013 | $333,000 | – | 5,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |